Cetrofirst 0.25mg Injection
Marketer
Gufic Bioscience Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Cetrofirst 0.25mg Injection
Cetrofirst 0.25mg Injection, a gonadotropin-releasing hormone antagonist, treats female infertility. It suppresses premature egg release, preventing ovulation. Administered subcutaneously by a healthcare professional, self-injection is contraindicated. Your doctor or nurse will provide guidance on proper home injection techniques. Dosage and frequency are determined by your physician based on individual needs and treatment goals. Continue using this medication as directed. Common side effects include injection site reactions (redness, itching, swelling), nausea, and vomiting. Rotate injection sites on your abdomen daily to minimize irritation. Seek immediate medical attention for dizziness, fainting, abdominal pain, or severe vomiting. Prior to treatment, inform your doctor of any liver or kidney conditions, breastfeeding, or other medications you're currently using, as interactions may affect the drug's efficacy.
Primary Ingredients of Cetrofirst 0.25mg Injection
No information provided. Therefore, no rephrased text can be offered.
Uses of Cetrofirst 0.25mg Injection
Inability to conceive in women
Major Benefits of Cetrofirst 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cetrofirst 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Cetrofirst 0.25mg Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
How Cetrofirst 0.25mg Injection works:
During infertility treatment in women, premature egg release can occur before the eggs are mature enough for fertilization. Cetrofirst 0.25mg Injection inhibits a natural hormone, thus preventing the premature ovarian release of eggs.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Cetrofirst 0.25mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Cetrofirst 0.25mg Injection during pregnancy poses a substantial risk. Pregnant individuals should consult their physician; research in animal models and human studies indicates considerable adverse effects on fetal development.
Breast feedingUNSAFE
Administration of Cetrofirst 0.25mg Injection is contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Administering Cetrofirst 0.25mg Injection typically has no impact on driving capabilities.
KidneyCAUTION
Patients with kidney impairment should use Cetrofirst 0.25mg Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised. Cetrofirst 0.25mg Injection is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Cetrofirst 0.25mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cetrofirst 0.25mg Injection :
Omit a Cetrofirst 0.25mg Injection dose? Seek medical advice immediately.
Facts to Know About Cetrofirst 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
| Action Class | GnRH receptor antagonists |
3,018 People bought this recently